ABSTRACT
Fetal pleural effusion is a rare congenital anomaly that occurs when some amount of fluid surrounds the fetal lung without concomitant hydrops. It may remain the same or progress more. We present here a case of a 32-year-old lady with primary infertility who conceived naturally. She presented to us for her routine term pregnancy evaluation. At 17 weeks her targeted imaging for fetal anomalies (TIFFA) scan revealed left side severe fetal hydrothorax. Again at 29 weeks left pleural effusion was noted. A C-section was performed at 38th week of pregnancy and a male child weighing 2.995 grams was born, with no need for ventilator support.
ABSTRACT
Pleural effusion is the accumulation of fluid in the pleural space due to disruption of the hydrostatic and starling forces which maintain the pressure of pleural cavity. A total of 42 dogs presented to Madras Veterinary College Teaching Hospital Small Animal Medicine Outpatient Unit with a history of cough and dyspnea were selected. Pleural effusion was diagnosed and classified into cardiac, hepatic and tumour and others group based on physical examination, radiography, electrocardiography, ultrasonography, echocardiography, cytological and biochemical evaluation of pleural fluid. The incidence of pleural effusion was 13.5% of the respiratory cases. Cytology of pleural fluid revealed the presence of lymphocytes, neutrophils, macrophages, RBCs, fibrin and mesothelial cells. Cytology of tumour group revealed mesothelioma (3), adenocarcinoma (1) and lymphoma (1). Cytology of other group revealed the presence of numerous RBCs and a few mesothelial cells in hemothorax and mature and degenerated neutrophils along with the presence of numerous clumps of bacteria and macrophages in pyothorax. Estimation of LDH of pleural effusion and ratio of pleural fluid to serum LDH was effective to classify pleural fluid into transudate, exudate and modified transudate
ABSTRACT
Resumen El quilotórax se produce ante la ruptura, desgarro u obstrucción del conducto torácico o sus afluentes principales, lo que resulta en la liberación de quilo al espacio pleural. Ocurre más frecuentemente asociado a trauma o a lesiones malignas; pero han sido descritas otras causas. El diagnóstico se obtiene mediante toracocentesis y la determinación de las concentraciones de triglicéridos y colesterol en el líquido pleural. Las complicaciones incluyen la desnutrición, inmunosupresión y compromiso respiratorio. El tratamiento puede ser conservador o agresivo en función de la situación clínica.
Abstract Chylothorax occurs when there is rupture, laceration or obstruction of the thoracic duct or its main tributaries, resulting in the release of chyle into the pleural space. It most commonly occurs from trauma or malignancy, but other causes have been described. Diagnosis involves thoracocentesis and cholesterol and triglyceride measurement in the pleural fluid. Complications include malnutrition, immunosuppression and respiratory distress. Treatment may be either conservative or aggressive depending on the clinical scenario.
Subject(s)
Humans , Adult , Middle Aged , Thoracostomy , Chyle , Chylomicrons , Chylothorax/diagnosis , Thoracic Cavity , ThoracentesisABSTRACT
Paragonimiasis is an important food-borne parasitic zoonosis caused by trematode species of the genus, Paragonimus occurring in many parts of the world except in Australia and Antarctica. In India, it is an emerging parasitic disease, which is endemic in the northeast states where people have a common practice of eating raw or inadequately cooked freshwater crabs. In these states, Paragonimus heterotremus has been identified as the major causative agent of the human paragonimiasis. The most common clinical form of the disease is pulmonary paragonimiasis; however, extra-pulmonary manifestations are not uncommon. Here, we report a case of primary massive unilateral pleural effusion due to paragonimiasis. The diagnosis was confirmed by finding Paragonimus ova in the pleural fluid. The patient was successfully treated with repeated thoracocentesis and a course of praziquantel.